Eris Lifesciences Ltd disclosed a Rs 45 crore term loan from Axis Bank in a BSE filing dated September 9, 2026. The Eris Lifesciences loan has been drawn down to meet other liabilities, according to the agreement details attached to the disclosure.

The company described the borrowing as a routine financial adjustment and said it would not affect its expected net debt figure at the end of the quarter. That statement relates to the quarter-end estimate; the filing does not provide a numerical net debt forecast.

Eris executed the term loan agreement on September 9, 2026. Its covering letter confirms that it entered into the agreement, while the accompanying disclosure specifies that the funds have been drawn down.

Loan security and outstanding borrowings

Under the disclosed security arrangement, Axis Bank will have a charge on the company’s brands. The supplied disclosure does not identify individual brands or state their valuation.

The loan agreement annexure lists the following amounts under total outstanding:

  • Term loan: Rs 155.77 crore.
  • Working capital loan: Rs 55 crore.

These figures appear in the borrowing details accompanying the Axis Bank agreement. The filing does not explicitly clarify whether the stated term loan outstanding includes the newly drawn Rs 45 crore, so the figures should not be combined to infer an additional borrowing total.

The supplied agreement details do not specify the interest rate, repayment schedule or loan tenure. The stated use of funds is to meet other liabilities, without a further breakdown of those obligations.

Disclosure contains an amount mismatch

The covering letter, purpose of the agreement and agreement size consistently state Rs 45 crore. However, one loan-details entry pairs the numerical amount of Rs 45 crore with words referring to sixty-four crore forty lakh. This report uses Rs 45 crore, the amount consistently identified elsewhere in the filing.

Eris submitted the disclosure under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The communication identifies the company by BSE security code 540596 and NSE symbol ERIS.

Source: BSE corporate announcement.